News
Forbidden Foods Ltd (ASX: FFF) is a multi-brand premium food company focusing on the infant & toddler and health & wellness plant-based markets. The Company was established with a vision to provide the very best foods to meet consumer demand for clean, sustainable, plant-based and healthy products.
The business sells products via its three brands – Blue Dinosaur®, FUNCH® and Sensory Mill® and is currently focused on the growth of Blue Dinosaur® in Australia and the USA, where it has established distribution partners and considerable ranging across bricks and mortar stores.
KEY PEOPLE
RELATED STOCKHEAD STORIES
News
Closing Bell: ASX dips as AGL stalls; Talga skyrockets after Sweden approves graphite mine
News
ASX Small Caps Lunch Wrap: Benchmark down, MinRes climbs on $1.1bn deal
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX climbs as Tech takes charge; CBA, AGL gain on earnings, LiveHire doubles
News
Top 10 at 11: Twin takeovers and fresh mining rights are making the news today
News
Rise and Shine: Everything you need to know before the ASX opens
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps and IPO Weekly Wrap: Things went better than expected in a week all about lithium and uranium
News
ASX Small Caps Lunch Wrap: Who’s marking the end of a home-delivered era today?
News
Top 10 at 11: It’s a mixed up kinda morning, but we’re moving in the right direction… for now
Health & Biotech
Obesity drug Wegovy takes the world by storm. Could that impact ASX stocks like Holista Colltech?
News
CLOSING BELL: Lithium Australia’s MinRes deal was a bright shining light on an otherwise dreary day
Tech
These tech and pharma stocks are looking to M&A to drive growth in global markets
Food & Agriculture
Forbidden Foods appoints new CEO, reshuffles its board to pursue US market expansion
Food & Agriculture
Forbidden Foods bolsters US footprint after signing distribution and retail deals
News
Good Morning Vietnam: These ASX companies are doing a roaring trade in the ‘Tiger Cub economy’
Health & Biotech